These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26629172)

  • 1. Effect of cardiac shock wave therapy on the microvolt T wave alternans of patients with coronary artery disease.
    Zhao L; Yang P; Tang Y; Li R; Peng Y; Wang Y; Pu L; Guo T
    Int J Clin Exp Med; 2015; 8(9):16463-71. PubMed ID: 26629172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease.
    Yang P; Guo T; Wang W; Peng YZ; Wang Y; Zhou P; Luo ZL; Cai HY; Zhao L; Yang HW
    Heart Vessels; 2013 May; 28(3):284-91. PubMed ID: 22457097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study.
    Čelutkienė J; Burneikaitė G; Shkolnik E; Jakutis G; Vajauskas D; Čerlinskaitė K; Zuozienė G; Petrauskienė B; Puronaitė R; Komiagienė R; Butkuvienė I; Steponėnienė R; Misiūra J; Laucevičius A
    Cardiovasc Ultrasound; 2019 Jul; 17(1):13. PubMed ID: 31272465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWARMI pilot trial: The value and optimal criteria of microvolt T-wave alternans in the diagnosis of reversible myocardial ischemia in patients without structural cardiac disease.
    Puljevic M; Danilowicz-Szymanowicz L; Molon G; Puljevic D; Raczak G; Canali G; Velagic V; Pezo-Nikolic B; Milicic D
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12610. PubMed ID: 30383318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvolt T-wave alternans in adult patients with repaired tetralogy of Fallot.
    Bartczak A; Trojnarska O; Cieplucha A; Plaskota K; Kramer L; Grajek S
    Congenit Heart Dis; 2015; 10(2):E89-97. PubMed ID: 25421856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study.
    Jia N; Zhang R; Liu B; Liu B; Qi X; Lan M; Liu J; Zeng P; Chen C; Li W; Guo Y; Yao Z; He Q
    J Nucl Cardiol; 2022 Oct; 29(5):2404-2419. PubMed ID: 34476776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Effect of Cardiac Shock Wave Therapy on Myocardial Ischemia in Patients With Ischemic Heart Failure.
    Wang W; Liu H; Song M; Fang W; Yuan F
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):381-7. PubMed ID: 26657563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Slow Coronary Artery Flow on Microvolt T-Wave Alternans.
    Surgit O; Erturk M; Akgul O; Gul M; Pusuroglu H; Akturk IF; Uzun F; Somuncu U; Ayaz A; Eksik A
    Acta Cardiol Sin; 2014 May; 30(3):190-6. PubMed ID: 27122788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvolt T-wave alternans in young myocardial infarction patients with preserved cardiac function treated with single-vessel primary percutaneous coronary intervention.
    Somuncu MU; Erturk M; Karakurt H; Demir AR; Bulut U; Kurtar A; Akbay E; Akgul O
    Arch Med Sci Atheroscler Dis; 2016; 1(1):e68-e74. PubMed ID: 28905024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shock-Wave Therapy Improves Myocardial Blood Flow Reserve in Patients with Refractory Angina: Evaluation by Real-Time Myocardial Perfusion Echocardiography.
    Ceccon CL; Duque AS; Gowdak LH; Mathias W; Chiang HP; Sbano JCN; Lima MF; Machado Cesar LA; Cruz CBBV; Dourado PMM; Meneghetti C; Tsutsui JM
    J Am Soc Echocardiogr; 2019 Sep; 32(9):1075-1085. PubMed ID: 31235421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac shock wave therapy improves myocardial perfusion and preserves left ventricular mechanics in patients with refractory angina: A study with speckle tracking echocardiography.
    Duque AS; Ceccon CL; Mathias W; Majesky JD; Gowdak LH; Sbano JCN; Cesar LAM; Abduch MC; Lima MSM; Dourado PMM; Cruz CBBV; Tsutsui JM
    Echocardiography; 2018 Oct; 35(10):1564-1570. PubMed ID: 29962073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Cardiac Shockwave Therapy in Severe Coronary Artery Disease Patients after Coronary Artery Bypass Grafting.
    Wang J; Jia N; Liu B; Zhang R; Liu B; Lan M; Liu J; Yao Z; He Q
    Int Heart J; 2023 Mar; 64(2):137-144. PubMed ID: 36927932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction.
    Daniłowicz-Szymanowicz L; Kaufmann D; Rozwadowska K; Kempa M; Lewicka E; Raczak G
    PLoS One; 2018; 13(5):e0196812. PubMed ID: 29723261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease.
    Wang Y; Guo T; Cai HY; Ma TK; Tao SM; Sun S; Chen MQ; Gu Y; Pang JH; Xiao JM; Yang XY; Yang C
    Clin Cardiol; 2010 Nov; 33(11):693-9. PubMed ID: 21089114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac shock wave therapy and myocardial perfusion in severe coronary artery disease.
    Kaller M; Faber L; Bogunovic N; Horstkotte D; Burchert W; Lindner O
    Clin Res Cardiol; 2015 Oct; 104(10):843-9. PubMed ID: 25893568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extracorporeal cardiac shock wave therapy for treatment of coronary artery disease].
    Wang Y; Guo T; Cai HY; Ma TK; Tao SM; Chen MQ; Gu Y; Pan JH; Xiao JM; Zhao L; Yang XY; Yang C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):711-5. PubMed ID: 21055138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of microvolt T-wave alternans in patients with coronary artery disease.
    Fuchs T; Leitman M; Zysman I; Amini T; Torjman A
    Isr Med Assoc J; 2012 Jun; 14(6):359-62. PubMed ID: 22891396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.